drugset / Trial / NCT01347086
Single Rising Dose Study of BI 207127 NA in Healthy Male Asian Volunteers and Single Dose Study of BI 207127 NA in Healthy Male Caucasian Volunteers
RandomizedParallel-groupDouble-blindTreatment
Summary
The aim of the study is to evaluate safety, tolerability and pharmacokinetics in Asian and Caucasian healthy male volunteers administered BI 207127 NA.
Timeline
- Start
- 2011-05
- Primary completion
- 2011-06
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Deleobuvir | Small molecule | 400 mg | Oral |
| Subject | Deleobuvir | Small molecule | 800 mg | Oral |
| Subject | Deleobuvir | Small molecule | 1200 mg | Oral |
Indications
No indication recorded.